Please Wait
Applying Filters...
menu
    • menu
    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Orelabrutinib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    InnoCare Doses First Patient In Ph 3 ICP-248 Trial For CLL/SLL
    InnoCare Doses First Patient In Ph 3 ICP-248 Trial For CLL/SLL

    27 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250327019292/en/InnoCare-Announces-First-Patient-Dosed-in-the-Phase-III-Registrational-Trial-of-BCL2-Inhibitor-ICP-248-in-Combination-with-Orelabrutinib-as-First-Line-Therapy-for-Treatment-of-CLLSLL-Patients-in-China

    BUSINESSWIRE
    27 Mar 2025
    Share Share
    InnoCare Presents Orelabrutinib MS Data At ACTRIMS 2025
    InnoCare Presents Orelabrutinib MS Data At ACTRIMS 2025

    26 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250226590199/en

    BUSINESSWIRE
    26 Feb 2025
    Share Share
    InnoCare Gets China Nod For Ph III Study Of ICP-248 In CLL/SLL
    InnoCare Gets China Nod For Ph III Study Of ICP-248 In CLL/SLL

    17 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250217973889/en

    BUSINESSWIRE
    17 Feb 2025
    Share Share
    AngioDynamic Receive FDA Clearance for NanoKnife Prostate Ablation
    AngioDynamic Receive FDA Clearance for NanoKnife Prostate Ablation

    09 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241209958174/en

    BUSINESSWIRE
    09 Dec 2024
    Share Share
    InnoCare Presents Orelabrutinib Data at ASH 2024
    InnoCare Presents Orelabrutinib Data at ASH 2024

    09 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241209933281/en

    BUSINESSWIRE
    09 Dec 2024
    Share Share
    InnoCare's Orelabrutinib Data Presented At ESMO Congress 2024
    InnoCare's Orelabrutinib Data Presented At ESMO Congress 2024

    13 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240913406407/en

    BUSINESSWIRE
    13 Sep 2024
    Share Share